OptimizeRx Corporation (OPRX)

OptimizeRx Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	19.52	13.38	13.85	18.21	84.68	10.52
Short-Term Investments	-	-	-	55.93	-	-
Cash & Short-Term Investments	19.52	13.38	13.85	74.14	84.68	10.52
Cash Growth	21.04%	-3.41%	-81.32%	-12.45%	705.21%	-44.22%
Accounts Receivable	32.23	38.21	36.25	22.16	24.8	17.89
Other Receivables	1.75	-	1.04	-	-	-
Receivables	33.97	38.21	37.29	22.16	24.8	17.89
Prepaid Expenses	2.83	0.77	1.29	0.85	0.93	4.46
Other Current Assets	-	1.61	1.9	1.43	4.7	-
Total Current Assets	56.32	53.97	54.33	98.58	115.11	32.86
Property, Plant & Equipment	0.6	0.52	0.72	0.37	0.47	0.59
Goodwill	70.87	70.87	78.36	22.67	14.74	14.74
Other Intangible Assets	42.44	45.52	49.4	13.02	10.65	12.12
Other Long-Term Assets	0.1	0.3	0.57	0.01	0.01	0.01
Total Assets	170.32	171.17	183.37	134.65	140.99	60.33
Accounts Payable	2.04	2.16	2.23	1.55	0.61	0.62
Accrued Expenses	10.2	8.49	7.71	2.6	2.9	2.42
Current Portion of Long-Term Debt	3.3	2	2	-	-	-
Current Portion of Leases	0.21	0.17	0.22	0.09	0.09	0.12
Current Income Taxes Payable	-	0.32	0.05	-	-	-
Current Unearned Revenue	0.4	0.47	0.17	0.16	1.39	0.29
Other Current Liabilities	2.33	5.05	5.51	3.99	4.38	6.58
Total Current Liabilities	18.47	18.65	17.88	8.4	9.37	10.03
Long-Term Debt	24.8	30.82	34.23	-	-	-
Long-Term Leases	0.3	0.21	0.37	0.14	0.24	0.33
Long-Term Deferred Tax Liabilities	4.49	4.49	4.34	-	-	-
Total Liabilities	48.06	54.17	56.82	8.54	9.61	10.35
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	206.5	201.35	190.79	172.79	166.62	85.59
Retained Earnings	-84.26	-84.37	-64.26	-46.69	-35.25	-35.63
Treasury Stock	-0	-0	-0	-0	-	-
Shareholders' Equity	122.26	117	126.55	126.11	131.38	49.97
Total Liabilities & Equity	170.32	171.17	183.37	134.65	140.99	60.33
Total Debt	28.61	33.19	36.82	0.23	0.33	0.45
Net Cash (Debt)	-9.09	-19.81	-22.97	73.91	84.35	10.07
Net Cash Growth	-	-	-	-12.39%	737.84%	-44.95%
Net Cash Per Share	-0.48	-1.08	-1.34	4.16	4.77	0.68
Filing Date Shares Outstanding	18.64	18.49	18.18	17.1	17.88	16.81
Total Common Shares Outstanding	18.59	18.45	18.16	17.07	17.86	15.22
Working Capital	37.85	35.32	36.45	90.18	105.74	22.83
Book Value Per Share	6.58	6.34	6.97	7.39	7.36	3.28
Tangible Book Value	8.96	0.61	-1.2	90.41	105.99	23.11
Tangible Book Value Per Share	0.48	0.03	-0.07	5.30	5.93	1.52
Machinery	-	0.41	0.3	0.27	0.47	0.37

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q